Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,247 | -60,535 | -50,078 | -34,134 | -17,202 |
| Depreciation Amortization | 5,288 | 18,896 | 14,220 | 9,688 | 4,751 |
| Accounts receivable | -1,278 | -554 | 751 | 921 | 231 |
| Accounts payable and accrued liabilities | 970 | 585 | 1,079 | 248 | 162 |
| Other Working Capital | -9,401 | 8,770 | 4,537 | 3,310 | 1,643 |
| Other Operating Activity | 1,492 | 8,740 | 4,732 | 3,189 | 1,927 |
| Operating Cash Flow | $-16,176 | $-24,098 | $-24,759 | $-16,778 | $-8,488 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -77 | -1,566 | -1,388 | -834 | -692 |
| Purchase Of Investment | -186 | -6,276 | -1,450 | -1,452 | -1,183 |
| Sale Of Investment | N/A | 25,550 | 24,375 | 23,375 | 19,375 |
| Purchase Sale Intangibles | N/A | -50 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -50 | 0 | 0 | 0 |
| Investing Cash Flow | $-263 | $17,658 | $21,537 | $21,089 | $17,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 71 | 29,115 | 28,906 | 44 | 3 |
| Other Financing Activity | -129 | -118 | -90 | -90 | 0 |
| Financing Cash Flow | $-58 | $28,997 | $28,816 | $-46 | $3 |
| Exchange Rate Effect | 413 | 454 | 305 | 287 | 37 |
| Beginning Cash Position | 58,056 | 35,045 | 35,045 | 35,045 | 35,045 |
| End Cash Position | 41,972 | 58,056 | 60,944 | 39,597 | 44,097 |
| Net Cash Flow | $-16,084 | $23,011 | $25,899 | $4,552 | $9,052 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,176 | -24,098 | -24,759 | -16,778 | -8,488 |
| Capital Expenditure | -77 | -1,566 | -1,388 | -834 | -692 |
| Free Cash Flow | -16,253 | -25,664 | -26,147 | -17,612 | -9,180 |